Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Mappa di calore
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
THW
#5832
abrdn World Healthcare Fund
12.5
5
USD
+0.97%
Settore:
Finanziario
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.97%
Variazione Mensile
+3.55%
Variazione di 6 mesi
-3.24%
Variazione Annuale
+18.51%
Chiusura Precedente
12.4
3
Apertura
12.6
2
Bid
Ask
Minimo
12.5
5
High
12.6
2
Volume
20
Mercati
Mercato Azionario Statunitense
Finanziario
THW
Apri il grafico completo
Principali partecipazioni
Market Value
Shares
Weight %
uniQure NV
43.523 M
745.632 K
8.502%
AZN
AstraZeneca PLC
27.669 M
360.655 K
5.405%
LLY
Eli Lilly & Co
18.423 M
24.146 K
3.599%
SNY
Sanofi SA
17.980 M
380.927 K
3.512%
Roche Holding AG
17.085 M
408.646 K
3.338%
TEVA
Teva Pharmaceutical Industries Ltd
16.417 M
812.718 K
3.207%
Medtronic PLC
15.062 M
158.150 K
2.942%
ISRG
Intuitive Surgical Inc
12.592 M
28.155 K
2.460%
MRK
Merck & Co Inc
12.328 M
146.879 K
2.408%
DHR
Danaher Corp
11.356 M
57.277 K
2.218%
Oxford Biomedica PLC
10.282 M
1.371 M
2.009%
NVO
Novo Nordisk A/S
10.278 M
185.222 K
2.008%
CVS
CVS Health Corp
9.065 M
120.237 K
1.771%
BDX
Becton Dickinson & Co
8.896 M
47.528 K
1.738%
ZTS
Zoetis Inc
8.817 M
60.258 K
1.722%
BSX
Boston Scientific Corp
8.542 M
87.498 K
1.669%
TMO
Thermo Fisher Scientific Inc
8.526 M
17.579 K
1.666%
ARGX
Argenx SE
8.371 M
11.349 K
1.635%
Lonza Group AG
8.019 M
11.993 K
1.567%
Newamsterdam Pharma Co NV
7.822 M
275.023 K
1.528%
Notizie
THW: A Global Healthcare Fund With 11% Yield But Overpays The Distribution (NYSE:THW)
Never Cutters, Part 2: 5 More High Yield CEFs That Have Never Cut The Distribution
7 High-Yield CEFs That Have Never Cut The Distribution In 10 Years Plus
Abrdn World Healthcare Fund Q4 2025 Commentary (THW)
Thames Water seeks extension for super senior funding conditions
Abrdn World Healthcare Fund Q3 2025 Commentary (THW)
Daniel Thwaites reports 5% revenue growth amid cost pressures
HQH: Severely Underperforms Peers (NYSE:HQH)
THQ: Outperforms Peers But Has Limited Growth Potential
THW: Discounted Valuation Due To Higher Interest Rates (NYSE:THW)
CEF Insights: The Future Of Healthcare Investing
Daniel Thwaites reports solid results amid challenging conditions